Skip to main content

Table 8 Biochemical parameters (mean ± SD) at enrolling visit (week -4) and week 12 in VLCKD and HBD group

From: Very-low-calorie ketogenic diet vs hypocaloric balanced diet in the prevention of high-frequency episodic migraine: the EMIKETO randomized, controlled trial

 

VLCKD

HBD

F, p-value

WBC

 Week -4

6.50 ± 1.43

6.08 ± 1.69

F = 2.042, 0.161

 Week 12

5.74 ± 1.02

6.08 ± 1.44

 Δ

− 0.76 ± 1.50* p < 0.05

0.00 ± 1.82

Hematocrit

 Week -4

42.91 ± 9.26

41.14 ± 3.67

F = 0.069, P = 0.794

 Week 12

40.81 ± 2.28

39.75 ± 4.41

 Δ

− 2.09 ± 10.01

− 1.39 ± 3.09

PLT

 Week -4

268.96 ± 62.51

244.73 ± 61.21

F = 1.796, p = 0.188

 Week 12

245.28 ± 67.49

245.93 ± 83.25

 Δ

− 23.68 ± 54.96* p < 0.05

1.20 ± 59.95

Neutrophils

 Week -4

3.84 ± 1.04

3.58 ± 1.25

F = 1.414, p = 0.242

 Week 12

3.33 ± 0.86

3.52 ± 1.14

 Δ

− 0.51 ± 0.94* p < 0.05

− 0.06 ± 1.45

Lymphocytes

 Week -4

2.07 ± 0.41

2.00 ± 0.52

F = 0.235, p = 0.631

 Week 12

2.07 ± 0.43

2.07 ± 0.50

 Δ

0.002 ± 0.42

0.07 ± 0.41

Monocytes

 Week -4

0.38 ± 0.13

0.33 ± 0.12

F = 1.490,p = 0.230

 Week 12

0.30 ± 0.09

0.33 ± 0.15

 Δ

− 0.07 ± 0.12* p < 0.05

− 0.01 ± 0.18

Glycemia

 Week -4

98.81 ± 8.83

97.87 ± 10.11

F = 4.858,p = 0.033

 Week 12

93.73 ± 15.73

103.20 ± 14.25

 Δ

− 5.07 ± 14.14

5.33 ± 15.29

AST

 Week -4

18.76 ± 6.78

20.27 ± 5.92

F = 4.275,p = 0.046

 Week 12

18.36 ± 5.16

15.93 ± 3.01

 Δ

− 0.40 ± 5.95

− 4.33 ± 5.60* p < 0.05

ALT

 Week -4

21.48 ± 12.27

24.80 ± 14.02

F = 2.499, p = 0.122

 Week 12

18.60 ± 10.05

15.80 ± 6.32

 Δ

− 2.88 ± 12.07

− 9.0 ± 11.46*

GGT

 Week -4

22.00 ± 12.14

20.67 ± 8.96

F = 0.428, p = 0.517

 Week 12

18.16 ± 10.25

15.60 ± 4.76

 Δ

− 3.84 ± 5.65* p < 0.05

− 5.07 ± 5.89* p < 0.05

Creatinine

 Week -4

0.72 ± 0.11

0.69 ± 0.11

F = 0.004, p = 0.949

 Week 12

0.72 ± 0.10

0.72 ± 0.11

 Δ

0.029 ± 0.12

0.027 ± 0.10

Uric acid

 Week -4

4.31 ± 1.38

4.41 ± 0.77

F = 0.214, p = 0.647

 Week 12

4.37 ± 0.95

4.32 ± 0.94

 Δ

0.05 ± 1.03

− 0.09 ± 0.68

CRP

 Week -4

4.32 ± 5.22

3.47 ± 2.54

F = 2.026, p = 0.163

 Week 12

2.35 ± 2.33

3.96 ± 6.35

 Δ

− 1.97 ± 4.13* p < 0.05

0.49 ± 6.71

NLR

 Week -4

1.82 ± 0.43

1.81 ± 0.48

F = 1.108, p = 0.299

 Week 12

1.59 ± 0.41

1.87 ± 1.25

 Δ

− 0.22 ± 0.48* p < 0.05

0.059 ± 1.17

PLR

 Week -4

131.61 ± 38.60

129.20 ± 43.10

F = 1.624, p = 0.211

 Week 12

121.11 ± 28.58

130.44 ± 50.27

 Δ

− 10.46 ± 29.04

1.24 ± 25.93

CD3 + T lymphocytes

 Week -4

64.29 ± 12.77

63.57 ± 10.59

F = 0.772, p = 0.386

 Week 12

66.47 ± 16.38

70.50 ± 9.06

 Δ

2.17 ± 16.79

6.92 ± 13.79

CD4 + T lymphocytes

 Week -4

58.76 ± 12.18

62.71 ± 14.71

F = 0.040, p = 0.843

 Week 12

62.70 ± 13.63

67.71 ± 12.49

 Δ

3.93 ± 17.02

5.00 ± 12.61

CD8 + T lymphocytes

 Week -4

30.76 ± 10.56

26.78 ± 11.50

F = 0.018, p = 0.894

 Week 12

28.52 ± 12.27

25.21 ± 9.24

 Δ

− 2.23 ± 14.26

− 1.57 ± 14.20

CD19 + B lymphocytes

 Week -4

18.39 ± 10.14

15.78 ± 10.51

F = 0.092, p = 0.764

 Week 12

17.33 ± 9.69

16.14 ± 6.92

 Δ

− 1.06 ± 15.12

0.36 ± 10.77

CD3- CD16 + CD56 + NK cells

 Week -4

13.90 ± 8.26

15.78 ± 7.61

F = 0.267, p = 0.609

 Week 12

12.67 ± 8.83

12.43 ± 9.56

 Δ

− 1.22 ± 9.61

− 3.36 ± 14.80

Naïve CD4 + T lymphocytes

 Week -4

22.61 ± 14.51

21.86 ± 10.09

F = 0.103, p = 0.750

 Week 12

23.52 ± 13.65

20.79 ± 9.91

 Δ

0.90 ± 20.01

− 1.07 ± 13.88

Naïve CD8 + T lymphocytes

 Week -4

28.34 ± 13.20

27.64 ± 13.44

F = 0.405, p = 0.529

 Week 12

32.52 ± 15.24

27.50 ± 16.47

 Δ

4.18 ± 20.69

− 0.14 ± 18.00

Regulatory T cells

 Week -4

0.92 ± 0.98

1.23 ± 1.46

F = 0.007, p = 0.932

 Week 12

0.91 ± 1.50

1.29 ± 1.62

 Δ

− 0.005 ± 2.01

0.06 ± 2.35

Th17 lymphocytes

 Week -4

0.45 ± 0.52

0.35 ± 0.31

F = 1.415, p = 0.279

 Week 12

0.22 ± 0.17

0.95 ± 1.40

 Δ

− 0.22 ± 0.66

0.60 ± 1.23